Free Trial
→ Collect $7k per month from Tesla’s SECRET dividend (From Investors Alley) (Ad)

GeneDx Q2 2024 Earnings Report

GeneDx logo
$95.83 -5.75 (-5.66%)
As of 02/21/2025 04:00 PM Eastern
Earnings HistoryForecast

GeneDx EPS Results

Actual EPS
-$0.11
Consensus EPS
-$0.26
Beat/Miss
Beat by +$0.15
One Year Ago EPS
N/A

GeneDx Revenue Results

Actual Revenue
$70.51 million
Expected Revenue
$58.90 million
Beat/Miss
Beat by +$11.61 million
YoY Revenue Growth
N/A

GeneDx Announcement Details

Quarter
Q2 2024
Date
7/30/2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Full Screen Slide Deck
Powered by Quartr

GeneDx Earnings Headlines

GeneDx (NASDAQ:WGS) Price Target Raised to $80.00
February 21 at 2:55 AM | americanbankingnews.com
Brokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $70.67
February 21 at 1:33 AM | americanbankingnews.com
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
February 22, 2025 | Investors Alley (Ad)
GeneDx price target raised to $105 from $75 at Wells Fargo
February 20 at 8:29 AM | markets.businessinsider.com
GeneDx (NASDAQ:WGS) Hits New 52-Week High on Better-Than-Expected Earnings
February 20 at 1:19 AM | americanbankingnews.com
GeneDx price target raised to $135 from $118 at TD Cowen
February 19 at 8:55 PM | markets.businessinsider.com
See More GeneDx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GeneDx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your email.

About GeneDx

GeneDx (NASDAQ:WGS), through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

View GeneDx Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles